X4 Pharmaceuticals Correlations

XFOR Stock

USD 0.37 0.03 8.82%

The current 90-days correlation between X4 Pharmaceuticals and Kiora Pharmaceuticals is 0.13 (i.e., Average diversification). The correlation of X4 Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

X4 Pharmaceuticals Correlation With Market

Average diversification

The correlation between X4 Pharmaceuticals and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in X4 Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in XFOR Stock, please use our How to Invest in X4 Pharmaceuticals guide.

Moving together with XFOR Stock

0.61	VRAX	Virax Biolabs Group	Pair Corr
0.83	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.71	INZY	Inozyme Pharma	Pair Corr
0.87	KURA	Kura Oncology	Pair Corr
0.61	STOK	Stoke Therapeutics	Pair Corr
0.75	BDRX	Biodexa Pharmaceticals Upward Rally	Pair Corr
0.7	TERN	Terns Pharmaceuticals	Pair Corr
0.68	PPERY	Bank Mandiri Persero	Pair Corr
0.68	PPERF	Bank Mandiri Persero	Pair Corr

Moving against XFOR Stock

0.74	PRAX	Praxis Precision Med	Pair Corr
0.71	EWTX	Edgewise Therapeutics	Pair Corr
0.67	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.57	ALVO	Alvotech	Pair Corr
0.52	AKRO	Akero Therapeutics	Pair Corr
0.51	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.45	VRDN	Viridian Therapeutics	Pair Corr
0.8	SSNLF	Samsung Electronics	Pair Corr
0.78	PTAIF	PT Astra International	Pair Corr
0.77	WMT	Walmart Aggressive Push	Pair Corr
0.76	DIS	Walt Disney Aggressive Push	Pair Corr
0.75	BAC	Bank of America Fiscal Year End 10th of January 2025	Pair Corr
0.73	CVX	Chevron Corp Fiscal Year End 7th of February 2025	Pair Corr
0.73	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.72	TRV	The Travelers Companies Fiscal Year End 17th of January 2025	Pair Corr

Related Correlations Analysis

	KPRX	ZVSA	SONN	ZURA	PHIO	RNAZ	QNRX
KPRX		0.41	0.25	0.14	0.33	-0.33	0.21	KPRX
ZVSA	0.41		0.68	-0.08	0.34	-0.19	-0.05	ZVSA
SONN	0.25	0.68		0.03	0.55	-0.22	-0.02	SONN
ZURA	0.14	-0.08	0.03		0.25	0.54	0.29	ZURA
PHIO	0.33	0.34	0.55	0.25		0.14	-0.14	PHIO
RNAZ	-0.33	-0.19	-0.22	0.54	0.14		-0.03	RNAZ
QNRX	0.21	-0.05	-0.02	0.29	-0.14	-0.03		QNRX
	KPRX	ZVSA	SONN	ZURA	PHIO	RNAZ	QNRX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SONN	+ 0.68	ZVSA
PHIO	+ 0.55	SONN
RNAZ	+ 0.54	ZURA
ZVSA	+ 0.41	KPRX
PHIO	+ 0.34	ZVSA
PHIO	+ 0.33	KPRX

High negative correlations

RNAZ	- 0.33	KPRX
RNAZ	- 0.22	SONN
RNAZ	- 0.19	ZVSA
QNRX	- 0.14	PHIO
ZURA	- 0.08	ZVSA
QNRX	- 0.05	ZVSA

Risk-Adjusted Indicators

There is a big difference between XFOR Stock performing well and X4 Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze X4 Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
KPRX	2.77	(0.29)	0.00	(0.26)	0.00	0.00	5.95	(4.97)	16.59
ZVSA	4.67	(0.99)	0.00	0.60	0.00	0.00	9.17	(10.36)	78.93
SONN	4.76	(0.77)	0.00	2.19	0.00	0.00	12.31	(9.79)	37.58
ZURA	3.78	(0.36)	0.00	(0.09)	0.00	0.00	7.95	(7.94)	30.69
PHIO	4.53	(0.30)	0.00	(0.18)	0.00	0.00	11.78	(10.38)	36.22
RNAZ	7.63	1.05	0.10	(0.44)	6.52	(11.84)	22.00	(11.43)	68.80
QNRX	6.21	0.47	0.07	0.37	6.73	(8.82)	17.65	(9.68)	74.46

X4 Pharmaceuticals Corporate Management

Robert Arbeit	Senior Research	Profile
Mary DiBiase	Chief Officer	Profile
Keith MD	Founder Board	Profile
Pharm MPH	Vice Communications	Profile
Renato Skerlj	Founder	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC